SlideShare a Scribd company logo
1 of 16
SCREENING MODELS FOR ANTI MICROBIAL
ACTIVITY
1
 An antimicrobial is an agent kills m.o’s or inhibits their
growth
 Antimicrobial medicines can be grouped according to the
m.o’s they act primarily against- antibiotics are used to
against bacteria and antifungal against fungi
 Anti bacterial used to treat bacterial infections, toxicity to
humans and other animals from antibacterial is generally
considered low
2
ANTIBACTERIAL SCREENING MODELS
 MOUSE SYSTEMIC INFECTION MODEL
 RABBIT SKIN BURN INFECTION MODEL
 MOUSE ASCENDING URINARY TRACT INFECTION
MODEL
3
MOUSE SYSTEMIC INFECTION MODEL
PRINCIPLE:
o The in vivo efficacy of test against mouse systemic infections was
determined with strains of E.coli, Klebsiella pneumoniae,S.aureus.
o Test showed broad –spectrum in vivo activity in the MSI model
4
REQUIREMENTS:
 Animal :CD-11 CR mice (18-21g)/ 10 mice per gp,5 males
&5 females
 S.c inj 0.5ml 5% mucin
 Diff.doses of test& ref.cpds
5
PROCEDURE :
• 18-21 g of mice were selected randomly 7 distributed into 21
groups with 5 gps for each cpd and 1 control
• Mice were I.P infected with 0.5ml of a bacterial suspension in 5%
mucin
• Diff.doses of test & reference cpds (saline for the control)were
administerd S.C 15min& 6h after infection, respectively
• Doses of test were 0.32-1.59mg/kg for E.coli infections, 0.1-
0.5mg/kg for K.pneumoniae, 0.16-2.5mg/kg forS.aureus
6
OBSERVATION:
• Deaths in each gp ED50 & 95% confidence limits were determined
RESULT :
o In general, test showed broad spectrum activity against
gram –ve and +ve bacteria
7
RABBIT SKIN BURN INFECTION MODEL
PRINCIPLE :
 The skin burn infection study was carried out with 6 male New
Zealand White rabbits infected with bact.suspension
REQUIREMENTS :
 Animal : new Zealand white rabbits (6 male) / 2.5-3kg
 Challenge dose, 1 x 107 CFU/burn wound
 Barium sulfide ZnO Starch paste
 Anesthesia : pentoibarbital Na (30mg/kg of B.W)
 75% et-OH
8
PROCEDURE :
 6 male white rabbits infected with E.coli
 one day before infection, the back hair of the animals was clipped
and then removed by applying a paste of BaSO4-ZnO starch (2:3:3
wt/wt/wt)
 On the day of infection ,the rabbits were anesthetized by IV inj.of
pentobarbital Na (30mg/kg of BW) and the back skin of the
animals were sterilized with 75% ET-oh.
 7 deep 2nd degree burn wounds ( 6 for admin.cpds and 1 for
control)were then created on the back of each animal by applying a
brass probe (dia 1.8cm , heated to 100°C for 10s
9
 15 min later 0.1ml (challenging dose 1x10⁷CFU/burn wound) of
an E.coli suspension in saline was I.C injected into each wound%&
home made cap used for protecting the wound
 1 hr after the burning 0.4ml of diff.cpd soln or saline (for the
control) was administered to the corresponding wound by loading it
onto a sterile gauze patch of the same size as the burn wound
 Sterile petrolactum contain gauze was used on top of the cpd
containing gauze to keep the wound humid
 The rabbits were sacrificed24 h after admin. of the cpds .
10
OBSERVATION :
 Full thickness skin biopsy samples were taken from the center of
the burns sterility and homogenized in saline
 the homogenates were serially 10 fold diluted &0.1ml aliquots were
spread onto nutrient agar plates
 The plates were incubated at 35°c for 48h, and no. of viable
organism in the burn wounds were determined
EVALUATION
 Test cpds which reduce the viable colony counts is compared to
that of the control group
11
MOUSE ASCENDING UTI MODEL
PRINCIPLE :
 The therapeutic efficacy of test drugs in mouse ascending UTI
caused by E.Coli bact.suspension was evaluated with female CD-11
CR mice. Test drugs exhibited a high degree of dose dependent
efficacy against bacterial suspension
REQUIREMENTS:
 Animal : CD-11CR mice ( 20-22g 10 mice /gp F)
 challenge dose, 2.2 x109 CFU/mouse
 Test cpds
 Anesthesia ; pentobarbital Na 0.05ml
12
 Saline & test cpds were admin, SC at 6,24,30,48 & 54h post
infection.
 Mice were sacrificed 72 h after infection
 PROCEDURE :
 Female mice of 20-220gm body weight were selected randomly and
grouped into 10mice /gp
 5 diff.doses of tests were used
 The mice were subjected to water restriction for 24 hrs prior to &
after infection
13
 Under anesthesia a round point needle was inserted trans urethrally
for inj.0.05ml of the bacterial suspension in 5% mucin into the
bladder
 Urethral needle was removed immediately after inoculation &
external urethral meatus clamped for 1 h
14
15
OBSERVATION:
 Kidneys were removed and homogenized in saline , the
homogenates serially diluted 10-fold diluted , & 0.1 ml aliquots were
spread onto agar plates
 Plates were incubated at 35◦c for 48h & no. of viable organism in
the kidney (CFU/ gm) were determined
EVALUATION
 Test cpds which reduce no. of viable organism in the kidney is
compared to that of the control group
16
THANK YOU.......

More Related Content

What's hot

Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agentsSravani Ganti
 
Screening of Drugs of Atherosclerosis
Screening of Drugs of AtherosclerosisScreening of Drugs of Atherosclerosis
Screening of Drugs of AtherosclerosisJaineel Dharod
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
 
Genetic variation and its role in health and pharmacology
Genetic variation and its role in health and pharmacologyGenetic variation and its role in health and pharmacology
Genetic variation and its role in health and pharmacologyGagandeep Jaiswal
 
Pre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugsPre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugsAaqib Naseer
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugsMy_VivJaan
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxinAfreen Hashmi
 
Evaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsEvaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsDr. Jill Mathew
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3pharmacologyseminars
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)ANANYAPANDEY71
 
genetic variations and its role in health/ pharmacology
genetic variations and its role in health/ pharmacologygenetic variations and its role in health/ pharmacology
genetic variations and its role in health/ pharmacologysrivani mandaloju
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugsDr Roohana Hasan
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsSwaroopaNallabariki
 
Screening methods for anti angina
Screening methods for anti anginaScreening methods for anti angina
Screening methods for anti anginaDiana Lou
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugsSindhoora Shetty
 

What's hot (20)

Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Screening of Drugs of Atherosclerosis
Screening of Drugs of AtherosclerosisScreening of Drugs of Atherosclerosis
Screening of Drugs of Atherosclerosis
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
 
Genetic variation and its role in health and pharmacology
Genetic variation and its role in health and pharmacologyGenetic variation and its role in health and pharmacology
Genetic variation and its role in health and pharmacology
 
Pre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugsPre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugs
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Genetic Variations in Drug Transporters
Genetic Variations in Drug TransportersGenetic Variations in Drug Transporters
Genetic Variations in Drug Transporters
 
Anti Inflammatory test
Anti Inflammatory testAnti Inflammatory test
Anti Inflammatory test
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
 
Evaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsEvaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugs
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)
 
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE  AND CALCIUM UPT...
PRINCIPLE AND APPLICATIONS OF CELL VIABILITY, GLUCOSE UPTAKE AND CALCIUM UPT...
 
genetic variations and its role in health/ pharmacology
genetic variations and its role in health/ pharmacologygenetic variations and its role in health/ pharmacology
genetic variations and its role in health/ pharmacology
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
 
Screening methods for anti angina
Screening methods for anti anginaScreening methods for anti angina
Screening methods for anti angina
 
Oecd guidline
Oecd guidlineOecd guidline
Oecd guidline
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 

Similar to anti microbial screening models

Expt 2- To determine anti-allergic activity by mast cell stabilization assay.
Expt 2- To determine anti-allergic activity by mast cell stabilization assay.Expt 2- To determine anti-allergic activity by mast cell stabilization assay.
Expt 2- To determine anti-allergic activity by mast cell stabilization assay.MirzaAnwarBaig1
 
screening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide sharescreening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide shareAnkitha868680
 
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsAnupam dubey
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationpradnya Jagtap
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testMerial EMEA
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulatorsAanchal46
 
SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptxSourinDe2
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayHimikaRathi
 
Lab Presentation 8.1.16
Lab Presentation 8.1.16Lab Presentation 8.1.16
Lab Presentation 8.1.16Declan Feery
 
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)St John's Laboratory Ltd
 
IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)iosrphr_editor
 
Immunodulators Screening methods
Immunodulators Screening methodsImmunodulators Screening methods
Immunodulators Screening methodsANANYAPANDEY71
 
Screening models for immunomodulators
Screening models for immunomodulatorsScreening models for immunomodulators
Screening models for immunomodulatorsurmisthasarkar
 
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...Ashish Gadage
 
Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agentsChandragiri Siva Sai
 

Similar to anti microbial screening models (20)

Expt 2 drug allergy
Expt 2  drug allergyExpt 2  drug allergy
Expt 2 drug allergy
 
Expt 2- To determine anti-allergic activity by mast cell stabilization assay.
Expt 2- To determine anti-allergic activity by mast cell stabilization assay.Expt 2- To determine anti-allergic activity by mast cell stabilization assay.
Expt 2- To determine anti-allergic activity by mast cell stabilization assay.
 
screening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide sharescreening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide share
 
Rabies
Rabies Rabies
Rabies
 
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
 
Inflamation ppt
Inflamation pptInflamation ppt
Inflamation ppt
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
 
SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptx
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assay
 
Lab Presentation 8.1.16
Lab Presentation 8.1.16Lab Presentation 8.1.16
Lab Presentation 8.1.16
 
FMDV
FMDVFMDV
FMDV
 
F0532031033
F0532031033F0532031033
F0532031033
 
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)
Immunofluorescence Antibody Validation Report for Anti-CK8 Antibody (STJ96957)
 
IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)IOSR Journal of Pharmacy (IOSRPHR)
IOSR Journal of Pharmacy (IOSRPHR)
 
Immunodulators Screening methods
Immunodulators Screening methodsImmunodulators Screening methods
Immunodulators Screening methods
 
Screening models for immunomodulators
Screening models for immunomodulatorsScreening models for immunomodulators
Screening models for immunomodulators
 
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...
Navigating the Landscape: Innovative Screening Models for Anti-Inflammatory D...
 
Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agents
 

Recently uploaded

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 

Recently uploaded (20)

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 

anti microbial screening models

  • 1. SCREENING MODELS FOR ANTI MICROBIAL ACTIVITY 1
  • 2.  An antimicrobial is an agent kills m.o’s or inhibits their growth  Antimicrobial medicines can be grouped according to the m.o’s they act primarily against- antibiotics are used to against bacteria and antifungal against fungi  Anti bacterial used to treat bacterial infections, toxicity to humans and other animals from antibacterial is generally considered low 2
  • 3. ANTIBACTERIAL SCREENING MODELS  MOUSE SYSTEMIC INFECTION MODEL  RABBIT SKIN BURN INFECTION MODEL  MOUSE ASCENDING URINARY TRACT INFECTION MODEL 3
  • 4. MOUSE SYSTEMIC INFECTION MODEL PRINCIPLE: o The in vivo efficacy of test against mouse systemic infections was determined with strains of E.coli, Klebsiella pneumoniae,S.aureus. o Test showed broad –spectrum in vivo activity in the MSI model 4
  • 5. REQUIREMENTS:  Animal :CD-11 CR mice (18-21g)/ 10 mice per gp,5 males &5 females  S.c inj 0.5ml 5% mucin  Diff.doses of test& ref.cpds 5
  • 6. PROCEDURE : • 18-21 g of mice were selected randomly 7 distributed into 21 groups with 5 gps for each cpd and 1 control • Mice were I.P infected with 0.5ml of a bacterial suspension in 5% mucin • Diff.doses of test & reference cpds (saline for the control)were administerd S.C 15min& 6h after infection, respectively • Doses of test were 0.32-1.59mg/kg for E.coli infections, 0.1- 0.5mg/kg for K.pneumoniae, 0.16-2.5mg/kg forS.aureus 6
  • 7. OBSERVATION: • Deaths in each gp ED50 & 95% confidence limits were determined RESULT : o In general, test showed broad spectrum activity against gram –ve and +ve bacteria 7
  • 8. RABBIT SKIN BURN INFECTION MODEL PRINCIPLE :  The skin burn infection study was carried out with 6 male New Zealand White rabbits infected with bact.suspension REQUIREMENTS :  Animal : new Zealand white rabbits (6 male) / 2.5-3kg  Challenge dose, 1 x 107 CFU/burn wound  Barium sulfide ZnO Starch paste  Anesthesia : pentoibarbital Na (30mg/kg of B.W)  75% et-OH 8
  • 9. PROCEDURE :  6 male white rabbits infected with E.coli  one day before infection, the back hair of the animals was clipped and then removed by applying a paste of BaSO4-ZnO starch (2:3:3 wt/wt/wt)  On the day of infection ,the rabbits were anesthetized by IV inj.of pentobarbital Na (30mg/kg of BW) and the back skin of the animals were sterilized with 75% ET-oh.  7 deep 2nd degree burn wounds ( 6 for admin.cpds and 1 for control)were then created on the back of each animal by applying a brass probe (dia 1.8cm , heated to 100°C for 10s 9
  • 10.  15 min later 0.1ml (challenging dose 1x10⁷CFU/burn wound) of an E.coli suspension in saline was I.C injected into each wound%& home made cap used for protecting the wound  1 hr after the burning 0.4ml of diff.cpd soln or saline (for the control) was administered to the corresponding wound by loading it onto a sterile gauze patch of the same size as the burn wound  Sterile petrolactum contain gauze was used on top of the cpd containing gauze to keep the wound humid  The rabbits were sacrificed24 h after admin. of the cpds . 10
  • 11. OBSERVATION :  Full thickness skin biopsy samples were taken from the center of the burns sterility and homogenized in saline  the homogenates were serially 10 fold diluted &0.1ml aliquots were spread onto nutrient agar plates  The plates were incubated at 35°c for 48h, and no. of viable organism in the burn wounds were determined EVALUATION  Test cpds which reduce the viable colony counts is compared to that of the control group 11
  • 12. MOUSE ASCENDING UTI MODEL PRINCIPLE :  The therapeutic efficacy of test drugs in mouse ascending UTI caused by E.Coli bact.suspension was evaluated with female CD-11 CR mice. Test drugs exhibited a high degree of dose dependent efficacy against bacterial suspension REQUIREMENTS:  Animal : CD-11CR mice ( 20-22g 10 mice /gp F)  challenge dose, 2.2 x109 CFU/mouse  Test cpds  Anesthesia ; pentobarbital Na 0.05ml 12
  • 13.  Saline & test cpds were admin, SC at 6,24,30,48 & 54h post infection.  Mice were sacrificed 72 h after infection  PROCEDURE :  Female mice of 20-220gm body weight were selected randomly and grouped into 10mice /gp  5 diff.doses of tests were used  The mice were subjected to water restriction for 24 hrs prior to & after infection 13
  • 14.  Under anesthesia a round point needle was inserted trans urethrally for inj.0.05ml of the bacterial suspension in 5% mucin into the bladder  Urethral needle was removed immediately after inoculation & external urethral meatus clamped for 1 h 14
  • 15. 15 OBSERVATION:  Kidneys were removed and homogenized in saline , the homogenates serially diluted 10-fold diluted , & 0.1 ml aliquots were spread onto agar plates  Plates were incubated at 35◦c for 48h & no. of viable organism in the kidney (CFU/ gm) were determined EVALUATION  Test cpds which reduce no. of viable organism in the kidney is compared to that of the control group